Insider Trading activities of Avi Biopharma Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avi Biopharma Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Avi Biopharma Inc since year 2005. Table 2 shows the detailed insider transactions of Avi Biopharma Inc since 2005. The reporting company's ticker symbol is SRPT. The reporting company's CIK number is 873303.
The total value of stock buying since 2005 is $9,727,716.
The total value of stock sales since 2005 is $26,123,654.
The total value of stock option exercises since 2005 is $5,120,559.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Avi Biopharma Inc (SRPT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 11,500 $575,000 11,500 $169,740
2017-08 0 $0 0 $0 78,015 $0
2017-07 47,058 $1,999,965 103,056 $4,249,210 92,138 $1,459,291
2016-11 0 $0 0 $0 6,000 $98,779
2016-10 0 $0 30,000 $1,502,490 30,000 $417,000
2016-09 0 $0 147,703 $7,438,910 121,842 $959,382
2016-03 154,500 $2,470,070 0 $0 0 $0
2015-02 1,600 $18,904 0 $0 0 $0
2013-11 10,000 $139,480 15,933 $200,134 0 $0
2013-09 6,500 $240,779 5,556 $194,315 5,556 $97,341
2013-08 9,000 $285,459 0 $0 0 $0
2013-06 10,000 $385,040 0 $0 0 $0
2012-11 0 $0 20,000 $552,786 0 $0
2012-09 17,500 $258,037 33,000 $474,243 0 $0
2012-03 30,000 $38,850 0 $0 0 $0
2011-12 300,000 $173,700 0 $0 0 $0
2011-09 20,000 $24,000 0 $0 0 $0
2011-04 250,000 $375,000 0 $0 0 $0
2010-08 9,000 $18,365 0 $0 0 $0
2010-07 0 $0 1,617,000 $2,818,607 1,617,000 $1,919,026
2010-06 53,500 $75,831 51,338 $63,659 0 $0
2010-05 215,607 $292,410 0 $0 0 $0
2010-03 0 $0 4,116,073 $5,109,287 0 $0
2009-11 0 $0 333,950 $475,878 0 $0
2009-08 880,000 $915,750 0 $0 0 $0
2009-03 69,400 $45,179 0 $0 0 $0
2008-09 0 $0 100,000 $112,331 0 $0
2008-08 6,582 $8,030 0 $0 0 $0
2008-06 0 $0 4,048 $5,667 0 $0
2008-05 0 $0 15,000 $23,460 0 $0
2008-03 687,470 $1,114,879 0 $0 0 $0
2008-02 573,200 $787,488 0 $0 0 $0
2006-08 0 $0 300,000 $811,380 0 $0
2006-07 0 $0 540,000 $1,516,297 0 $0
2006-03 5,000 $31,800 0 $0 0 $0
2005-11 2,000 $6,740 0 $0 0 $0
2005-09 10,000 $21,960 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Avi Biopharma Inc insiders (SRPT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-03 Ruff Shamim (SVP, Regulatory Affairs & Qual) Sale 11,500 50.00 575,000
2017-10-03 Ruff Shamim (SVP, Regulatory Affairs & Qual) Option Ex 11,500 14.76 169,740
2017-08-03 Cumbo Alexander (SVP, Chief Commercial Officer) Option Ex 9,752 .00 0
2017-08-03 Ruff Shamim (SVP, Regulatory Affairs & Qual) Option Ex 8,865 .00 0
2017-08-03 Howton David T (SVP, General Counsel) Option Ex 10,639 .00 0
2017-08-03 Kaye Edward M. Md (Director) Option Ex 35,461 .00 0
2017-08-03 Mahatme Sandesh (EVP, CFO & CBO) Option Ex 13,298 .00 0
2017-07-27 Ingram Douglas S (President & CEO) Buy 47,058 42.50 1,999,965
2017-07-21 Ruff Shamim (SVP, Regulatory Affairs & Qual) Sale 5,888 44.00 259,072
2017-07-21 Ruff Shamim (SVP, Regulatory Affairs & Qual) Option Ex 5,888 14.33 84,375
2017-07-21 Howton David T (SVP, General Counsel) Option Ex 1,000 18.78 18,780
2017-07-21 Mahatme Sandesh (EVP, CFO & CBO) Option Ex 1,500 23.85 35,775
2017-07-20 Cumbo Alexander (SVP, Chief Commercial Officer) Sale 5,918 41.00 242,638
2017-07-20 Cumbo Alexander (SVP, Chief Commercial Officer) Option Ex 2,500 13.71 34,275
2017-07-20 Ruff Shamim (SVP, Regulatory Affairs & Qual) Sale 6,250 42.00 262,500
2017-07-20 Ruff Shamim (SVP, Regulatory Affairs & Qual) Option Ex 6,250 13.71 85,687
2017-07-20 Howton David T (SVP, General Counsel) Sale 25,000 41.00 1,025,000
2017-07-20 Howton David T (SVP, General Counsel) Option Ex 25,000 13.71 342,750
2017-07-20 Kaye Edward M. Md (Director) Sale 10,000 41.00 410,000
2017-07-20 Mahatme Sandesh (EVP, CFO & CBO) Sale 50,000 41.00 2,050,000
2017-07-20 Mahatme Sandesh (EVP, CFO & CBO) Option Ex 50,000 17.15 857,649
2016-11-09 Howton David T (SVP, General Counsel) Option Ex 1,000 23.85 23,850
2016-11-09 Kaye Edward M. Md (President, CEO & CMO) Option Ex 3,000 8.28 24,839
2016-11-09 Mahatme Sandesh (Senior Vice President, CFO) Option Ex 1,000 23.85 23,850
2016-11-08 Ruff Shamim (SVP, Regulatory Affairs & Qual) Option Ex 1,000 26.24 26,240
2016-10-17 Mahatme Sandesh (Senior Vice President, CFO) Sale 30,000 50.08 1,502,490
2016-10-17 Mahatme Sandesh (Senior Vice President, CFO) Option Ex 30,000 13.90 417,000
2016-09-22 Ruff Shamim (SVP, Regulatory Affairs & Qual) Sale 7,311 60.00 438,660
2016-09-22 Ruff Shamim (SVP, Regulatory Affairs & Qual) Option Ex 7,311 13.90 101,622
2016-09-22 Howton David T (SVP, General Counsel) Sale 7,000 60.00 420,000
2016-09-22 Howton David T (SVP, General Counsel) Option Ex 7,000 13.90 97,300
2016-09-22 Kaye Edward M. Md (President, CEO & CMO) Sale 40,179 60.00 2,410,740
2016-09-22 Kaye Edward M. Md (President, CEO & CMO) Option Ex 40,179 8.28 332,682
2016-09-19 Aphale Jayant (VP, Technical Operations) Sale 35,000 50.00 1,750,000
2016-09-19 Aphale Jayant (VP, Technical Operations) Option Ex 35,000 4.62 161,700
2016-09-19 Howton David T (SVP, General Counsel) Sale 9,304 50.00 465,200
2016-09-19 Howton David T (SVP, General Counsel) Option Ex 8,000 13.90 111,200
2016-09-19 Kaye Edward M. Md (President, CEO & CMO) Sale 24,352 50.00 1,217,600
2016-09-19 Kaye Edward M. Md (President, CEO & CMO) Option Ex 24,352 6.36 154,878
2016-09-14 Kaye Edward M. Md (SVP Interim CEO & CMO) Sale 24,557 30.00 736,710
2016-03-16 Behrens M Kathleen (Director) Buy 10,000 14.54 145,430
2016-03-14 Barry Richard (Director) Buy 75,000 15.66 1,174,200
2016-03-14 Price Ben Gil (Director) Buy 4,500 16.70 75,145
2016-03-14 Behrens M Kathleen (Director) Buy 65,000 16.54 1,075,295
2015-02-27 Kaye Edward M. Md (SVP & Chief Medical Officer) Buy 800 11.81 9,452
2015-02-27 Christopher Nishan Garabedian (President and CEO) Buy 800 11.81 9,452
2013-11-14 Chase Anthony R (Director) Buy 10,000 13.95 139,480
2013-11-12 Aphale Jayant (SVP Technical Operations) Sale 15,933 12.56 200,134
2013-09-16 Behrens M Kathleen (Director) Buy 6,500 37.04 240,779
2013-09-03 Hodgman John (Director) Sale 5,556 34.97 194,315
2013-09-03 Hodgman John (Director) Option Ex 5,556 17.52 97,341
2013-08-22 Chase Anthony R (Director) Buy 3,500 32.68 114,372
2013-08-20 Mahatme Sandesh (Senior Vice President, CFO) Buy 5,000 31.10 155,500
2013-08-19 Price Ben Gil (Director) Buy 500 31.18 15,587
2013-06-14 Chase Anthony R (Director) Buy 10,000 38.50 385,040
2012-11-28 Chase Anthony R (Director) Sale 8,900 29.36 261,286
2012-11-27 Chase Anthony R (Director) Sale 1,100 29.04 31,940
2012-11-14 Chase Anthony R (Director) Sale 10,000 25.96 259,560
2012-09-07 Chase Anthony R (Director) Sale 33,000 14.37 474,243
2012-09-07 Behrens M Kathleen (Director) Buy 17,500 14.74 258,037
2012-03-14 Price Ben Gil (Director) Buy 30,000 1.29 38,850
2011-12-15 Christopher Nishan Garabedian (President and CEO) Buy 300,000 .58 173,700
2011-09-13 Chase Anthony R (Director) Buy 20,000 1.20 24,000
2011-04-06 Christopher Nishan Garabedian (President and CEO) Buy 130,000 1.50 195,000
2011-04-06 Price Ben Gil (Director) Buy 20,000 1.50 30,000
2011-04-06 Behrens M Kathleen (Director) Buy 100,000 1.50 150,000
2010-08-27 Boyle J David Ii (CEO) Buy 5,000 2.13 10,645
2010-08-13 Price Ben Gil (Director) Buy 4,000 1.93 7,720
2010-07-30 Hudson Leslie (Former CEO) Sale 183,486 1.93 354,127
2010-07-30 Hudson Leslie (Former CEO) Option Ex 183,486 1.09 199,999
2010-07-28 Hudson Leslie (Former CEO) Sale 183,486 1.83 335,412
2010-07-28 Hudson Leslie (Former CEO) Option Ex 183,486 1.09 199,999
2010-07-26 Hudson Leslie (Former CEO) Sale 129,083 1.91 246,161
2010-07-26 Hudson Leslie (Former CEO) Option Ex 129,083 1.45 187,170
2010-07-23 Hudson Leslie (Former CEO) Sale 205,400 1.80 369,720
2010-07-23 Hudson Leslie (Former CEO) Option Ex 205,400 1.45 297,830
2010-07-22 Hudson Leslie (Former CEO) Sale 265,517 1.80 477,930
2010-07-22 Hudson Leslie (Former CEO) Option Ex 265,517 1.45 384,999
2010-07-16 Hudson Leslie (Former CEO) Sale 100,028 1.88 187,652
2010-07-16 Hudson Leslie (Former CEO) Option Ex 100,028 1.09 109,030
2010-07-09 Hudson Leslie (Former CEO) Sale 200,000 1.59 317,800
2010-07-09 Hudson Leslie (Former CEO) Option Ex 200,000 1.09 218,000
2010-07-07 Hudson Leslie (Former CEO) Sale 200,000 1.47 294,400
2010-07-07 Hudson Leslie (Former CEO) Option Ex 200,000 .92 184,000
2010-07-06 Hudson Leslie (Former CEO) Sale 21,089 1.53 32,371
2010-07-06 Hudson Leslie (Former CEO) Option Ex 21,089 .92 19,401
2010-07-02 Hudson Leslie (Former CEO) Sale 128,911 1.57 203,034
2010-07-02 Hudson Leslie (Former CEO) Option Ex 128,911 .92 118,598
2010-06-24 Hudson Leslie (Former CEO) Sale 51,338 1.24 63,659
2010-06-11 Price Ben Gil (Director) Buy 7,000 1.44 10,080
2010-06-09 Chase Anthony R (Director) Buy 46,500 1.41 65,751
2010-05-21 Chase Anthony R (Director) Buy 50,000 1.33 66,500
2010-05-18 Chase Anthony R (Director) Buy 11,068 1.43 15,771
2010-05-17 Chase Anthony R (Director) Buy 18,539 1.41 26,139
2010-05-13 Price Ben Gil (Director) Buy 40,000 1.36 54,400
2010-05-12 Chase Anthony R (Director) Buy 96,000 1.35 129,600
2010-03-24 Hudson Leslie (Former CEO) Sale 21,427 1.49 31,926
2010-03-04 Eastbourne Capital Management Llc/ca (10% Owner) Sale 4,094,646 1.24 5,077,361
2009-11-11 Eastbourne Capital Management Llc/ca (10% Owner) Sale 333,950 1.43 475,878
2009-08-25 Haywood George Weaver (Other) Buy 430,000 .68 290,250
2009-08-21 Haywood George Weaver (Other) Buy 450,000 1.39 625,500
2009-03-16 Price Ben Gil (Director) Buy 20,400 .67 13,688
2009-03-13 Price Ben Gil (Director) Buy 30,000 .65 19,350
2009-03-13 Boyle J David Ii (CFO) Buy 19,000 .64 12,141
2008-09-03 Kole Ryszard (Senior Vice President) Sale 38,200 1.12 42,745
2008-09-02 Kole Ryszard (Senior Vice President) Sale 61,800 1.13 69,586
2008-08-15 Price Ben Gil (Director) Buy 6,582 1.22 8,030
2008-06-03 Kole Ryszard (Senior Vice President) Sale 4,048 1.40 5,667
2008-05-20 Kole Ryszard (SENIOR VICE PRESIDENT) Sale 15,000 1.56 23,460
2008-03-31 Haywood George Weaver (10% Owner) Buy 156,423 1.83 286,254
2008-03-27 Haywood George Weaver (10% Owner) Buy 27,842 1.75 48,723
2008-03-26 Haywood George Weaver (10% Owner) Buy 100,000 1.74 174,000
2008-03-25 Haywood George Weaver (10% Owner) Buy 100,000 1.72 172,000
2008-03-24 Haywood George Weaver (10% Owner) Buy 100,400 1.50 150,600
2008-03-12 Haywood George Weaver (10% Owner) Buy 110,130 1.44 158,587
2008-03-11 Haywood George Weaver (10% Owner) Buy 55,375 1.39 76,971
2008-03-10 Haywood George Weaver (10% Owner) Buy 37,300 1.28 47,744
2008-02-20 Haywood George Weaver (10% Owner) Buy 11,000 1.41 15,510
2008-02-19 Haywood George Weaver (10% Owner) Buy 100,000 1.41 141,000
2008-02-15 Haywood George Weaver (10% Owner) Buy 7,200 1.34 9,648
2008-02-13 Haywood George Weaver (10% Owner) Buy 150,000 1.42 212,700
2008-02-12 Haywood George Weaver (10% Owner) Buy 240,000 1.38 330,240
2008-02-11 Haywood George Weaver (10% Owner) Buy 65,000 1.21 78,390
2006-08-10 Haywood George Weaver (10% Owner) Sale 35,940 2.68 96,318
2006-08-09 Haywood George Weaver (10% Owner) Sale 164,060 2.71 444,602
2006-07-27 Haywood George Weaver (10% Owner) Sale 360,300 2.71 975,692
2006-07-26 Haywood George Weaver (10% Owner) Sale 36,000 2.95 106,200
2006-07-25 Haywood George Weaver (10% Owner) Sale 143,700 3.02 434,405
2006-03-17 Bowman Jack L (Director) Buy 5,000 6.36 31,800
2005-11-23 Hicks James B (Director) Buy 2,000 3.37 6,740
2005-09-07 Forrest K Michael (Director) Buy 10,000 2.20 21,960

Insider trading activities including stock purchases, stock sales, and option exercises of SRPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avi Biopharma Inc (symbol SRPT, CIK number 873303) see the Securities and Exchange Commission (SEC) website.